http://www.acc.org/Feed?clinicalTopicID=c5ff91a9-f0f4-4291-84b8-6604ce7c4778 Clinical Topic Feed: Cardiac Surgery and Heart Failure en /Latest-in-Cardiology/Articles/2026/07/22/13/15/eagles-eye-view-22jul2026 In this week’s View, Dr. Eagle looks at age, body mass index (BMI), and cardiovascular outcomes after transcatheter aortic valve replacement (TAVR). 1784726220000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/15/14/19/eagles-eye-view-15jul2026 In this week’s View, Dr. Eagle looks at the feasibility of mechanical leaflet splitting in high-risk patients undergoing valve-in-valve transcatheter aortic valve replacement (TAVR). 1784125200000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/01/12/47/eagles-eye-view-01jul2026 In this week’s View, Dr. Eagle looks at how genotype independently predicts heart failure outcomes in patients with hypertrophic cardiomyopathy (HCM). 1782910140000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/23/13/25/Genotype-Independently-Predicts-HF-Outcomes In patients with hypertrophic cardiomyopathy (HCM), genotype, peak VO2, log NT-proBNP and LVEF independently predict heart failure (HF) outcomes, and combining these measures identified patients at higher risk of HF-related death or transplant, according to a recent study published in JACC: Heart Failure. 1782228900000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1780315620000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/20/13/40/eagles-eye-view-20may2026 In this week’s View, Dr. Eagle reviews evidence supporting the use of cardiac magnetic resonance (CMR) and NT-proBNP in hypertrophic cardiomyopathy (HCM) risk assessment. 1779288780000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/JACC-Journals-Science-at-ESC-Heart-Failure-Congress-2026 Findings from several studies presented at ESC Heart Failure Congress 2026 in Barcelona, Spain, were simultaneously published in JACC and JACC: Heart Failure, covering topics like arrhythmic burden in cardiac amyloidosis (CA), stroke and bleeding risk in CA... 1778607960000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-surviv-acc-2026 Among patients with a failed mitral bioprosthetic valve, transcatheter mitral valve-in-valve (mVIV) treatment was associated with a lower rate of death or disabling stroke at one year compared with standard repeat mitral valve replacement surgery (rMVR), according to results from the SURVIV study presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans. 1774818000000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/03/12/18/40/JACC-State-of-the-Art With the population of stage D heart failure (HF) patients supported with durable left ventricular assist devices (dLVAD) rapidly expanding, a State-of-the-Art Review published in JACC provides a comprehensive overview of support and management of dLVAD-related emergencies, with an intent to provide a rapid-response guide for clinicians who encounter emergencies in patients with dLVADs. 1773343260000 Articles and Stories /Latest-in-Cardiology/Articles/2026/02/19/11/58/Hot-Topics-in-Congenital-and-Pediatric-Cardiology-in-the-Year-2025 The pace of innovation in congenital and pediatric cardiology continued to accelerate in 2025, shaped by practice‑defining guidelines, multicenter investigations, and growing bench‑to‑bedside translation. 1771850460000 Articles and Stories